FTY720 in combination with cyclosporine-an analysis of skin allograft survival and renal function

International Immunopharmacology

Volumn 6, Issue 13-14, 2006, Pages 1911-1918

  Silva, Francieli Ruiz ^a   Silva, Lea Bueno Lucas ^b   Cury, Patricia Maluf ^c   Burdmann, Emmanuel Almeida ^c   Bueno, Valquiria ^c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNORP   (Brazil)

^c FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

Immunosuppression; Renal function; T lymphocytes; Transplantation

Indexed keywords

CYCLOSPORIN A; FINGOLIMOD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY FUNCTION; KIDNEY STRUCTURE; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT;

ANIMALS; BODY WEIGHT; CELL COUNT; CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; LYMPH NODES; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POTASSIUM; PROPYLENE GLYCOLS; SKIN TRANSPLANTATION; SODIUM; SPHINGOSINE; SPLEEN; TRANSPLANTATION, HOMOLOGOUS;

EID: 33845342550     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.07.014     Document Type: Article

References (30)

1. Young B.A., Burdmann E.A., Johnson R.J., Andoh T., Bennett W.M., and Couse W.G. Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int 48 (1995) 431-438
2. Young B.A., Budmann E.A., Johnson R.J., Alpers C.E., Giachelli C.M., and Eng E. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 48 (1995) 439-448
3. Li C., Lim S.W., Sun B.K., Choi B.S., GLowacka S., Cox A., et al. Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal. Acta Pharmacol Sin 25 (2004) 401-411
4. Thomas S.E., Andoh T.F., Pichler R.H., Shankland S.J., Couser W.G., and Bennett W.M. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 53 (1998) 897-908
5. Maki T., Gottschalk R., Ogawa N., and Monaco A.P. Prevention and cure of autoimmune diabetes in no obese diabetic mice by continuous administration of FTY720. Transplantation 79 (2005) 1051-1055
6. Azuma H., Takahara S., Horie S., Muto S., Otsuki Y., and Katsuoka Y. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. J Urol 169 (2003) 2372-2377
7. Schmid G., Guba M., Papyan A., Ischenko I., Bruckel M., Bruns C.J., et al. FTY720 inhibits tumor growth and angiogenesis. Transplant Proc 37 (2005) 110-111
8. Ueda H., Takahara S., Itoh S., Nomi H., Shibahara N., and Katsuoka Y. Preoperative administration of FTY720 prolonged renal allograft survival. Transpl Immunol 14 (2005) 1-8
9. Oliveira C.M., Borra R.C., Franco M., Schor N., Pestana J.O., and Bueno V. FTY720 impairs necrosis development after ischemia-reperfusion injury. Transplant Proc 36 (2004) 854-856
10. Suleiman M., Cury P.M., Pestana J.O., Burdmann E.A., and Bueno V. FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury. Transplant Proc 37 (2005) 373-374
11. Wang M.E., Tejpal N., Qu X., Yu J., Okamoto M., Stepkowski, et al. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Transplantation 65 (1998) 899-905
12. Koshiba T., Van Damme B., Rutgeerts O., Waer M., and Pirenne J. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. Transplantation 75 (2003) 945-952
13. Kovarik J.M., Schmouder R.L., Barilla D., Buche M., Rouilly M., Berthier S., et al. FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction. Ann Pharmacother 38 (2004) 1153-1158
14. Troncoso P., Stepkowski S.M., Wang M.E., Qu X., Chueh S.C., Clark J., et al. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine. Transplantation 67 (1999) 145-151
15. Tawadrous M.N., Mabuchi A., Zimmermann A., and Wheatley A.M. Effects of immunosuppressant FTY720 on renal and hepatic hemodynamics in the rat. Transplantation 74 (2002) 602-610
16. Galvao V.R., Ginoza M., Franco M., Burdmann E.A., and Bueno V. Prolonged administration of FTY720 does not cause renal toxicity in mice. Transplant Proc 37 (2005) 112-113
17. Lima R.S.M., Nogueira-Martins M.F., Silva Jr. H.T., Pestana J.O.M., and Bueno V. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination. Transplant Proc 36 (2004) 1015-1017
18. Kim J.Y., Lim S.W., Li C., Kim J.S., Ahn K.O., Yang H.J., et al. Effect of FTY720 on chronic cyclosporine nephropathy in rats. Transplantation 80 (2005) 1323-1330
19. Matloubian M., Lo C.G., Cinamon G., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004) 355-360
20. Hussain I., Piepenbrink M.S., Fitch K.J., Marsh J.A., and Dietert R.R. Developmental immunotoxicity of cyclosporine-A in rats: age-associated differential effects. Toxicology 206 (2005) 273-284
21. Chen M.F., Suzuki H., Maruyama M., and Yano S. The influence of FK-506 on the thymus and spleen in normal C3H/He mice: flow cytometric analysis of lymphocyte subpopulations. Immunol Lett 29 (1991) 255-259
22. Zhang Q., Chen Y., Fairchild R.L., Heeger P.S., and Valujskikh A. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol 176 (2006) 770-777
23. Sawicha E., Dubois G., Jarai G., Edwards M., Thomas M., Nicholls A., et al. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity. J Immunol 175 (2005) 7973-7980
24. Lee Y.R., Yang I.H., Lee Y.H., Im S.A., Song S., Li H., et al. Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 105 (2005) 3951-3955
25. Kahan B.D. Individuality: the barrier to optimal immunosuppression. Nature 3 (2003) 831-838
26. Rafaeli Y., Van Parijs L., London C.A., Tschopp J., and Abbas A.K. Biochemical mechanisms of IL-2-regulated Fas-mediated T-cell apoptosis. Immunity 8 (1998) 615-623
27. Wolf M., Schimpl A., and Hning T. Control of T-cell hyperactivation in IL-2-deficient mice by CD4+CD25- and CD4+CD25+ T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol 31 (2001) 1637-1645
28. + regulatory T cells. J Immunol 174 (2005) 6993-7005
29. Abe K., Li K., Sacks S.H., and Sheerin N.S. The m membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol 136 (2004) 60-66
30. Bohdanecka M., Schuck O., Chadimova M., Sedivy J., Glagolicova A., Skibova J., et al. The effect of omega-3 fatty acids and vitamin E on the nephrotoxicity of cyclosporine A in hereditary hypertriglyceridemic rats. Physiol Res 48 (1999) 437-443